Mitchell J. Frederick

11.4k citations

79 papers · 3.2k indexed · h-index 31

Otorhinolaryngology top 1%
- Head and Neck Cancer Studies 7
Oncology top 2%
- Cancer-related Molecular Pathways 24
Cancer Research top 5%
- Cancer-related molecular mechanisms research 7
Immunology top 5%
Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 7
Molecular Biology
- RNA modifications and cancer 15
- Cancer-related gene regulation 8
- Epigenetics and DNA Methylation 6
- Cell death mechanisms and regulation 5

Co-authors: Gary L. Clayman Ying C. Henderson Adel K. El‐Naggar Jeffrey N. Myers Curtis R. Pickering Arumugam Jayakumar Mary Wang Kenji Mitsudo
Cited by: Otorhinolaryngology Oncology Cancer Research
Journals: Clinical Cancer Research (11 papers)Cancer Research (11 papers)Head & Neck (4 papers)
Partner nations: United States Japan China

In The Last Decade

Mitchell J. Frederick

73 papers receiving 3.1k citations

Peers

Countries citing papers authored by Mitchell J. Frederick

Since Specialization

Citations

This map shows the geographic impact of Mitchell J. Frederick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell J. Frederick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell J. Frederick more than expected).

Fields of papers citing papers by Mitchell J. Frederick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell J. Frederick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell J. Frederick. The network helps show where Mitchell J. Frederick may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mitchell J. Frederick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell J. Frederick Line = papers co-authored together Mitchell J. Frederick links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reliable RNA-seq analysis from FFPE specimens as a means to accelerate cancer-related health disparities research PLoS ONE ·Mitchell J. Frederick,Dionigi Tettamanzi,Jirong Jin,Patricia Castro,Ikuko Miyai,Ikuko Miyai,Michael Stiffler,Joseph Cerra,Moisés Lemes da Silveira,Amy Hamlin,Thomas J. Ow,Heath D. Skinner,Vlad C. Sandulache	2025	0
2	Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma Clinical Cancer Research ·Rutulkumar Patel,香坂上,Lixia Luo,Yan Ma,Michael Stiffler,Nerissa T. Williams,Jeffrey I. Everitt,Sagar Balvir,Patricia Castro,William K. Decker,William Henry Hudson,Jeffrey N. Myers,Vlad C. Sandulache,Mitchell J. Frederick,Yvonne M. Mowery,David G. Kirsch	2025	0
3	Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients Oral Oncology ·Can Koyuncu,Mitchell J. Frederick,Lester D.�R. Thompson,Germán Corredor,Sirvan Khalighi,Zelin Zhang,敖伟波,Cheng Lu,Azam Vakili Arki,Vidya Sankar Viswanathan,雅純吉田,Kailin Yang,Shlomo A. Koyfman,Deborah J. Chute,Patricia Castro,James S. Lewis,Anant Madabhushi,Vlad C. Sandulache	2023	7
4	FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner Clinical Cancer Research ·Phillip M. Pifer,Liangpeng Yang,Manish Kumar,Tongxin Xie,Mitchell J. Frederick,Yinet Torres-Peña,Beth M. Beadle,David Molkentine,Jessica M. Molkentine,B. Copin,山中愼介,Abdullah A. Osman,Brian J. Leibowitz,Jeffrey N. Myers,Curtis R. Pickering,Vlad C. Sandulache,John V. Heymach,Heath D. Skinner	2023	13
5	Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma Clinical Cancer Research ·Abdullah A. Osman,Emre Arslan,Masinjara Irène Mahafeno,Chieko Michikawa,Antje Lindemann,Katarzyna Tomczak,Wangjie Yu,Vlad C. Sandulache,Wencai Ma,Li Shen,Jing Wang,Anand K. Singh,Mitchell J. Frederick,Nakia D. Spencer,João Vitor Benevides,Timothy P. Heffernan,W. Fraser Symmans,Kunal Rai,Jeffrey N. Myers	2023	32
6	Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus–Driven Cancers Clinical Cancer Research ·Soma Ghosh,Tuhina Mazumdar,Wei Xu,Reid T. Powell,Clifford Stephan,Li Shen,Qiaoyu Li,Curtis R. Pickering,Frederic Weiller,Jing Wang,Mitchell J. Frederick,Faye M. Johnson	2022	13
7	Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response Journal for ImmunoTherapy of Cancer ·Kazi Mokim Ahmed,Ratna Veeramachaneni,Defeng Deng,Nagireddy Putluri,Vasanta Putluri,Maria Cardenas,David A. Wheeler,William K. Decker,Abdelkhalik Ossama,Usman Saleem Khan Panni,Andrew G. Sikora,Vlad C. Sandulache,Mitchell J. Frederick	2022	29
8	Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell Carcinoma Cancer Research ·Qiaoyu Li,Vaishnavi Sambandam,美奈安元,Hongyun Zhao,Tuhina Mazumdar,Li Shen,Qi Wang,Kazi Mokim Ahmed,Soma Ghosh,Mitchell J. Frederick,Jing Wang,Faye M. Johnson	2022	8
9	Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress Molecular Cancer Therapeutics ·Antje Lindemann,Ameeta A. Patel,Lin Tang,Noriaki Tanaka,Frederico O. Gleber‐Netto,Masinjara Irène Mahafeno,Li Wang,Daniel J. McGrail,Shiaw‐Yih Lin,Steven J. Frank,Mitchell J. Frederick,Jeffrey N. Myers,Abdullah A. Osman	2021	18
10	High expression of oxidative phosphorylation genes predicts improved survival in squamous cell carcinomas of the head and neck and lung Scientific Reports ·Mitchell J. Frederick,Heath D. Skinner,Usman Saleem Khan Panni,Andrew G. Sikora,Vlad C. Sandulache	2020	30
11	PDK1 Mediates NOTCH1 -Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition Clinical Cancer Research ·Vaishnavi Sambandam,Mitchell J. Frederick,Li Shen,Pan Tong,Xiayu Rao,Shaohua Peng,Ratnakar Singh,Tuhina Mazumdar,Chenfei Huang,Qiuli Li,Curtis R. Pickering,Jeffery N. Myers,Jing Wang,Faye M. Johnson	2019	42
12	CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition Cancer Research ·Daniël F. Joubert,Jiexin Zhang,Li Shen,Xiayu Rao,Jing Wang,Mei Zhao,Nene N. Kalu,Faye M. Johnson,Lauren A. Byers,John V. Heymach,Walter N. Hittelman,Durga Udayakumar,Raj K. Pandita,Tej K. Pandita,Curtis R. Pickering,Abena B. Redwood,Helen Piwnica‐Worms,Katharina Schlacher,Mitchell J. Frederick,Jeffrey N. Myers	2017	34
13	Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins Clinical Cancer Research ·Noriaki Tanaka,Ameeta A. Patel,Jiping Wang,Mitchell J. Frederick,Nene N. Kalu,Mei Zhao,Alison L. Fitzgerald,Tongxin Xie,Natalie L. Silver,Carlos Caulı́n,Ge Zhou,Heath D. Skinner,Faye M. Johnson,Jeffrey N. Myers,Abdullah A. Osman	2015	46
14	Squamous Cell Carcinoma of the Oral Tongue in Young Non-Smokers Is Genomically Similar to Tumors in Older Smokers Clinical Cancer Research ·Curtis R. Pickering,Jiexin Zhang,David M. Neskey,Mei Zhao,Samar A. Jasser,Jiping Wang,Alexandra M. Ward,C. Jillian Tsai,Marcus V. Ortega Alves,Jane H. Zhou,Jennifer Drummond,Adel K. El‐Naggar,Richard A. Gibbs,John N. Weinstein,David A. Wheeler,Jing Wang,Mitchell J. Frederick,Jeffrey N. Myers	2014	118
15	Wee-1 Kinase Inhibition Overcomes Cisplatin Resistance Associated with High-Risk TP53 Mutations in Head and Neck Cancer through Mitotic Arrest Followed by Senescence Molecular Cancer Therapeutics ·Abdullah A. Osman,Marcus M. Monroe,Marcus V. Ortega Alves,Ameeta A. Patel,Panagiotis Katsonis,Alison L. Fitzgerald,David M. Neskey,Mitchell J. Frederick,Sang Hyeok Woo,Carlos Caulı́n,Muath K. Alsheik,Thomas O. McDonald,Marek Kimmel,Raymond E. Meyn,Olivier Lichtarge,Jeffrey N. Myers	2014	88
16	Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional p53 Molecular Cancer Therapeutics ·Daniël F. Joubert,T.-T. Tran-Thi,Marcus V. Ortega Alves,Curtis R. Pickering,Abdullah A. Osman,David M. Neskey,Mei Zhao,Alison L. Fitzgerald,Jeffrey N. Myers,Mitchell J. Frederick	2013	95
17	Establishment and Characterization of Novel Cell Lines from Sinonasal Undifferentiated Carcinoma Clinical Cancer Research ·Yoko Takahashi,Michael E. Kupferman,Diana Bell,Tilahun Jiffar,Concert Spirituel,Tongxin Xie,Ռուբեն Օհանջանյան,Mei Zhao,Mitchell J. Frederick,Alexander Gelbard,Jeffrey N. Myers,Ehab Y. Hanna	2012	23
18	Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model Clinical Cancer Research ·Сысоева Валентина Ивановна,Yunyun Chen,Daisuke Sano,Mitchell J. Frederick,Ge Zhou,Mei Zhao,Zvonimir L. Milas,Chad E. Galer,Ying C. Henderson,Samar A. Jasser,David A. Schwartz,James A. Bankson,Jeffrey N. Myers,Stephen Y. Lai	2011	68
19	BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells Cancer Research ·Thomas D. Shellenberger,Mary Wang,Sayaka Uda,Arumugam Jayakumar,Robert M. Strieter,Marie D. Burdick,Constantin G. Ioannides,강승삼,Adel K. El‐Naggar,Dianna Roberts,Gary L. Clayman,Mitchell J. Frederick	2004	204
20	Interleukin-1 Production in Tumor Cells of Human Melanoma Surgical Specimens Journal of Interferon & Cytokine Research ·Douglas S. Tyler,芳夫村井,Mitchell J. Frederick,Rupal Pimoli,Philip H. Barker,J. L. Smith,Omar Eton,Merrick I. Ross,Elizabeth A. Grimm	1995	16

About Mitchell J. Frederick

Mitchell J. Frederick is a scholar working on Otorhinolaryngology, Cancer Research and Oncology, having authored 79 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (24 papers), RNA modifications and cancer (15 papers), Cancer-related gene regulation (8 papers), Cancer-related molecular mechanisms research (7 papers), Head and Neck Cancer Studies (7 papers), Cell Adhesion Molecules Research (7 papers), Epigenetics and DNA Methylation (6 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Otorhinolaryngology (289 citations), Oncology (1.3k citations) and Cancer Research (644 citations). Mitchell J. Frederick has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Gary L. Clayman, Ying C. Henderson, Adel K. El‐Naggar, Jeffrey N. Myers, Curtis R. Pickering, Arumugam Jayakumar, Mary Wang, Kenji Mitsudo, Mei Zhao and Vlad C. Sandulache. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Head & Neck, Molecular Cancer Therapeutics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact